Method for measuring human neutrophil elastase
The method employs antibodies recognizing distinct epitopes on the neutrophil elastase-A1AT complex to overcome sensitivity issues in conventional assays, achieving effective detection in the presence of high A1AT levels.
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- SUMITOMO BAKELITE CO LTD
- Filing Date
- 2024-12-10
- Publication Date
- 2026-06-22
AI Technical Summary
Conventional immunoassays for neutrophil elastase suffer from reduced sensitivity due to the high presence of α1-antitrypsin (A1AT) in biological samples, which binds to anti-A1AT antibodies, hindering effective detection.
A method using two or more antibodies that recognize different epitopes on the complex of neutrophil elastase and its inhibitor, such as α1-antitrypsin, allowing for high-sensitivity detection without the need for additional inhibitor addition.
Enables sensitive detection of neutrophil elastase in samples with high A1AT levels by utilizing antibodies that specifically bind to the complex, enhancing assay performance.
Smart Images

Figure 2026100970000003 
Figure 2026100970000004 
Figure 2026100970000005